Corporate
Description
  • Value proposition

    Teva Pharmaceuticals has been developing and producing medicines to help improve people’s lives for more than a century. We are committed to being a global leader in generic and specialty medicines with a portfolio of 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day. They are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com.

    Please note that adverse effects for any of our products should be reported to: Safety.AE@teva.co.il

    Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here:
    http://www.tevapharm.com/contact_us/

    generic medicines, specialty medicines, CNS, active pharmaceutical ingredients, respiratory, biosimilars, biologics, pain care, migraine, and oncology

Entity interactions BETA
Entity TypeTweets Articles
Oxford Students Oxford Students
Other

26 Aug 2019


Idean UK Idean UK
it services, Design Services
Other

21 Feb 2020


hupstream hupstream
it services, Software Development
Other

22 Jun 2023


IEEE SENSORS IEEE SENSORS
deeptech, Non-profit Organizations
Other

29 Jul 2017


Zuken Zuken
it services, Software Development
Other

16 Dec 2021


COPD Foundation COPD Foundation
healthtech, Non-profit Organizations
Other

20 Aug 2018


ECTRIMS ECTRIMS
deeptech, Research Services
Other

11 Oct 2018


Digital Trends Media Group Digital Trends Media Group
Online Audio and Video Media
Other

25 Nov 2019


Front Line Genomics Front Line Genomics
Media Production
Other

2 Dec 2020


Allegheny Conference on Community Development Allegheny Conference on Community Development
martech, Non-profit Organizations
Other

26 Apr 2023


Radars
Loading...